Clik here to view.
UVDIが2023年感染管理疫学専門家協会会議で紫外線LEDによる表面除菌機「UVDI-GO™」を発表
カリフォルニア州バレンシア （ビジネスワイヤ） – UV-Cによる空気・表面除菌の先進技術を活用した製品を製造するリーディング企業UltraViolet Devices,...
View ArticleClik here to view.
UVDI将在APIC 2023推出全新的UVDI-GO™ UV LED表面消毒器
加利福尼亚州巴伦西亚 (美国商业资讯)–UltraViolet Devices, Inc.（UVDI）是一家行业领先的UV-C空气和表面先进消毒技术制造商。该公司将在6月26-28日期间在佛罗里达州奥兰多举行的2023年感染控制专业人员协会（Association for Professionals in Infection...
View ArticleClik here to view.
Kite Announces Completion of Marketing Authorization Transfer for Yescarta®...
SANTA MONICA, Calif. Kite Pharma, Inc., a Gilead Company (Nasdaq: GILD), today announced that the Marketing Authorization in Japan for Yescarta® (axicabtagene ciloleucel), a chimeric antigen...
View ArticleClik here to view.
スペインのLa Fe大学病院、術前診断においてMasimo W1™による遠隔医療プログラムを拡大
スイス、ノイシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は、スペインのバレンシアにあるLa Fe大学病院が高度な健康追跡用ウォッチMasimo W1™による遠隔医療および遠隔モニタリングプログラムを拡大すると発表しました。主要な生理学的パラメーターの正確な連続測定を行うMasimo W1は、Masimo...
View ArticleClik here to view.
Hospital La Fe利用Masimo W1™扩展面向术前患者的远程医疗项目
瑞士纳沙泰尔 (美国商业资讯)– Masimo（纳斯达克证券代码：MASI）今天宣布，西班牙瓦伦西亚的Hospital La Fe正在利用该公司先进的健康跟踪腕表Masimo W1™来扩展其远程医疗和远程监护项目。Masimo W1可准确、连续测量关键的生理参数，在美国境外可作为医疗器械使用，并可与Masimo SafetyNet®远程患者管理和远程医疗平台集成。Hospital La...
View ArticleClik here to view.
Microba Commences Phase I Clinical Trial for IBD Therapeutic
BRISBANE, Australia Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) today announces that the first participants have been successfully dosed in the Phase I Clinical Trial of...
View ArticleClik here to view.
Microba开始进行炎症性肠病(IBD)治疗的I期临床试验
澳大利亚布里斯班 (美国商业资讯)– Microba Life Sciences Limited (ASX: MAP)（以下简称“Microba”或“公司”）今天宣布，首批受试者已在MAP 315（Microba在炎症性肠病(IBD)领域的治疗项目）的I期临床试验中成功完成给药。这一里程碑将Microba的候选药物MAP 315引入临床开发阶段，作为溃疡性结肠炎患者的新潜在治疗方案。...
View ArticleClik here to view.
マイクロバ、IBD治療薬の第I相臨床試験を開始
オーストラリア、ブリスベン （ビジネスワイヤ） — マイクロバ・ライフサイエンス(ASX:MAP)（以下「マイクロバ」または「同社」）は、同社の炎症性腸疾患（IBD）治療プログラムの一環である開発中のMAP 315の第I相臨床試験において、最初の被験者への投与に成功したことを発表しました。このマイルストーンにより、マイクロバの医薬品候補MAP...
View ArticleClik here to view.
From blackboard to mortarboard: 23 scholars from 13 countries graduate from...
MEMPHIS, Tenn. ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital®, graduated the fourth cohort of the ALSAC Global Scholars Basic Fundraising Program on...
View ArticleClik here to view.
ASP Japan G.K. Informs the Opening of Yamato Factory – Toward Further Kaizen
TOKYO On July 1, 2023, ASP Japan, G.K. opened and began operations at its Yamato Factory in Yamato-city, Kanagawa Prefecture. This press release features multimedia. View the full release here:...
View ArticleClik here to view.
ASP Japan合同会社が大和工場を開設
東京 （ビジネスワイヤ） — 2023年7月1日、神奈川県大和市にASP Japan合同会社の大和工場を開設し、操業を開始いたしました。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：https://www.businesswire.com/news/home/20230703425148/ja/ ASP Japan合同会社 大和工場...
View ArticleClik here to view.
Rimini Support™ Enables Gachon University Gil Medical Center to Advance its...
LAS VEGAS Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP...
View ArticleClik here to view.
NTHU Hospital BOT Project in Taoyuan with over NT$10 Billion of Investment by...
HSINCHU, TAIWAN National Tsing Hua University (NTHU) in Taiwan signed a BOT hospital contract with privately owned Kaohsiung Medical University (KMU) on July 4th, with NTHU President W. John Kao...
View ArticleClik here to view.
Propanc Biopharma Peer Reviewed Scientific Article Reaches 3,000 Reads
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly,...
BREA, Calif. & TOKYO Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced a...
View ArticleClik here to view.
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 12th International AIDS Society Conference on HIV Science (IAS 2023), taking place in...
View ArticleClik here to view.
New Biktarvy® Data Presented at IAS 2023 Further Demonstrate Safety and...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from multiple studies reinforcing Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg...
View ArticleClik here to view.
Desktop Health™ Introduces the PrintRoll™ Rotating Build Platform for the...
BOSTON Desktop Health — the trusted production-grade medical 3D printing brand of Desktop Metal, Inc. (NYSE: DM) — today announced a breakthrough in bioprinting with the launch of PrintRoll™, an...
View ArticleClik here to view.
MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to...
YORBA LINDA, Calif. MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, today announced that its MediPines AGM100 non-invasive pulmonary gas exchange analyzer...
View ArticleClik here to view.
Mori Building to Open Azabudai Hills on November 24, 2023
TOKYO Mori Building Co., Ltd., Japan’s leading urban landscape developer, announced today that Azabudai Hills, a multi-use complex and new world-class neighborhood in Central Tokyo, will open on...
View Article